We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




BIT Analytical Expands Clinical Chemistry, Immunology, Molecular Offerings

By LabMedica International staff writers
Posted on 03 Jan 2011
BIT Analytical Instruments (Schwalbach, Germany) has acquired French original equipment manufacturer (OEM), diagnostics instruments firm, C2 Diagnostics (Montpellier, France). More...
The purchase price was not revealed.

The acquisition will enable BIT to offer a larger range of services and technologies in areas of clinical chemistry, immunology, and molecular diagnostics. BIT Companies provide a full, turnkey portfolio for in vitro diagnosis (IVD) market OEMs

C2 is a leader in contract development, design, manufacture, and support of custom instrumentation for the diagnostic equipment industry, with a specialty in hematology. The company specializes in developing OEM instruments and has delivered and sold more than 10,000 instruments to small and mid-size diagnostic labs worldwide. The company is currently focused on developing a new hematology instrument.

With expertise in mechanics, optics, software, electronics, fluidics, and chemistry, C2 Diagnostics (C2D) also holds several in vitro diagnostics (IVD) patents. The company has its own 929-m2 facility that is registered by the FDA as a contract manufacturer

C2D is currently focused on hematology application, which has an end-user segment with a growing market size. The company's product offering is a family of over 10 models of compact, easy to operate, robust, and cost efficient diagnostic instruments.

Related Links:

BIT Analytical Instrument
C2 Diagnostics




Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
Hematology Consumables
Bioblood Devices
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The Xpert Hemorrhagic Fever Panel test runs on Cepheid’s GeneXpert Dx systems (Photo courtesy of Cepheid)

WHO Emergency Listing Supports Rapid Molecular Testing for Ebola Outbreak Response

The Democratic Republic of the Congo is confronting an Ebola Bundibugyo outbreak that the World Health Organization (WHO) designated a Public Health Emergency of International Concern on May 17, 2026.... Read more

Microbiology

view channel
Image Credit: Adobe Stock

Gut Microbiome Classifier Improves Colorectal Cancer Risk Stratification

Colorectal cancer remains a leading cause of cancer mortality, and current noninvasive screening methods still miss many precancerous lesions. Clinicians therefore need tools that improve risk stratification... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.